• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Novartis Ag ADR (NY: NVS )

    101.54 UNCHANGED
    Streaming Delayed Price Updated: 7:00 PM EDT, Oct 2, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,358
    Open 101.54
    Bid (Size) 100.28 (13)
    Ask (Size) 100.40 (16)
    Prev. Close 101.54
    Today's Range 101.54 - 101.54
    52wk Range 74.24 - 105.61
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Novartis' Investigational Therapy Shows Promising Action In Rare Kidney Disease
    Novartis AG (NYSE: NVS) announced topline results from the pre-specified interim analysis of the Phase 3 APPLAUSE-IgAN study at nine months of iptacopan, an investigational factor B inhibitor targeting... 
    Via Benzinga
    Cardiol Therapeutics 76% YTD Gain Is A Bullish Signal Ahead Of Expected Phase III Trial Announcements ($CRDL)
    Via AB Newswire
    Topics Death
    Exposures Death Product Safety

    Performance

    YTD
    +10.12%
    +10.12%
    1 Month
    +3.52%
    +3.52%
    3 Month
    +2.80%
    +2.80%
    6 Month
    +9.75%
    +9.75%
    1 Year
    +32.44%
    +32.44%

    More News

    Read More
    Fusion Pharmaceuticals Poised For Leadership In Targeted Cancer Therapies: Oppenheimer
    Via Benzinga
    Allakos' Antibodies For Chronic Skin Conditions, Analyst Sees Over 400% Stock Upside
    Via Benzinga
    2 Dividend Stocks to Buy and Hold Forever
    Via The Motley Fool
    Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges
    Via Benzinga
    Health Insurer Centene Streamlines - Plans Massive Layoffs To Cut Costs: Report
    Via Benzinga
    Topics Workforce
    Exposures Layoff
    Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
    Via Benzinga
    Amazon Invests $4B In ChatGPT Competitor, Hollywood Writers Accept Tentative Deal, ChatGPT Challenges Siri And Alexa With Introduction Of Verbal Responses: Today's Top Stories
    Via Benzinga
    Novartis Sandoz Prepares For Public Debut With Strong Sales Record And Plans for New Biologic Drugs
    Via Benzinga
    Are Gene Therapy Stocks The Market's Next Big Winners?
    Via MarketBeat
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Novartis Precision Cancer Therapy Hits Primary Goal In Rare Type Of Pancreatic Cancer
    Via Benzinga
    Week In Review: Everest Acquires Novel Autoimmune Therapy In $132 Million Agreement
    Via Talk Markets
    AI To Revolutionize Clinical Trials And Diagnostics
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    From Years to Months: How AI is Shaping the Landscape of Clinical Trials
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Preventable Vaccines Market May See a Big Move : AstraZeneca, GlaxoSmithKline, Merck
    Via SBWire
    Amazon Poaches Microsoft's Product Chief, Google And DoD Team Up For AI-Powered Microscope To Identify Cancer, Rocket Lab's 41st Mission Succumbed To Technical Issues: Today's Top Stories
    Via Benzinga
    Chinese Drugmaker BeiGene And Novartis Move Out From Second Cancer Drug Pact
    Via Benzinga
    AMC Stock Alert: Adam Aron Teases New Chocolate, Wine Brands for AMC
    Via InvestorPlace
    Why Is Canopy Growth (CGC) Stock Up 14% Today?
    Via InvestorPlace
    Topics Cannabis
    Exposures Cannabis
    NVS Stock Alert: Novartis Shareholders Approve Sandoz Spinoff
    Via InvestorPlace
    Instacart Mulls IPO Price Hike After Arm's Stellar Debut, UAW Launches Historic Simultaneous Strike, China Sanctions Lockheed Martin & Northrop Grumman Concerning Taiwan Arms Sales: Today's Top Stories
    Via Benzinga
    Topics Initial Public Offering
    Exposures Securities Market
    Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?
    Via Investor's Business Daily
    Exposures Product Safety
    Sandoz Pushes Product Launch Plans As Novartis Shareholders Approve The Spin-Off
    Via Benzinga
    AI Integration In Biotech & Pharma: Companies Positioned To Benefit
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.